Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for CORVUS PHARMACEUTICALS, INC. COMMON STOCK (CRVS).
- Disclosed ownership: 10%.
- Date of event: 23 Jan 2026.
ORBIMED ADVISORS LLC - 23 Jan 2026 SCHEDULE 13D/A Report for CORVUS PHARMACEUTICALS, INC. COMMON STOCK (CRVS)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- CRVS
- Shares outstanding
- 83,583,408 shares
- Disclosed Ownership
- 8,609,091 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D/A
- Filing time
- 27 Jan 2026, 20:38:38 UTC
- Date of event
- 23 Jan 2026
- Previous filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 10% ownership in CORVUS PHARMACEUTICALS, INC. COMMON STOCK (CRVS) on 23 Jan 2026."
What Changed
- Previous schedule filing date: 14 May 2025.
- Current filing was accepted on 27 Jan 2026, 20:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | 8,609,091 | 0 | 8,609,091 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| ORBIMED CAPITAL GP V LLC | 10% | 8,609,091 | 0 | 8,609,091 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001615374 |